<?xml version="1.0" encoding="utf-8"?> 

<rss version="2.0"> 

<channel>

<title>LexisNexis&#174; Mealey's&#8482; Antidepressant Drugs Legal News</title>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

<description>Headline Antidepressant Drugs Legal News from LexisNexis&#174;</description>

<language>en-us</language>

<image>

<title>LexisNexis&#174; Headline Antidepressant Drugs Legal News</title>

<url>http://www.lexisnexis.com/mealeys/images/lexismealeyslogo.gif</url>

<width>130</width> 
  
<height>29</height>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

</image> 

<copyright>Copyright 2009</copyright>

<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>7th Circuit Says Post-2002 Effexor Warnings Were Properly Excluded</title>
<description>
<![CDATA[CHICAGO - Wyeth's victory in the nation's first federal Effexor suicide trial was upheld Feb. 12 by the Seventh Circuit U.S. Court of Appeals when it affirmed a district court judge's decision barring a widow from introducing evidence about Effexor's suicide warnings after her husband's death on the ground that the probative value of the post-2002 warnings was substantially outweighed by the danger of confusing the jury (Jacquelyn Giles v. Wyeth Inc., et al., No. 07-3149, 7th Cir.; 2009 U.S. App. LEXIS 2651; See January 2008, Page 15). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Judge: Birth Defect Case Would Not Benefit From MDL Proceedings</title>
<description>
<![CDATA[ST. LOUIS - A woman's claims that her use of Celexa during her pregnancy caused her son's death nine months after his birth should be remanded to the court where it was originally filed, the federal judge presiding over the federal multidistrict litigation involving attempted suicide and suicide claims allegedly caused by use of Celexa and Lexapro ruled Feb. 5, after finding that the case would not benefit from the proceedings (In re: Celexa &amp; Lexapro Products Liability Litigation, MDL No. 1736, Case No. 06-md-1736, Debra Drewry v. Forest Laboratories Inc., No. 06CV717, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Wyeth: Pfizer Deal Merits No Change In Preemption Case</title>
<description>
<![CDATA[WASHINGTON, D.C. - Wyeth on Feb. 4 told the U.S. Supreme Court about Pfizer Inc.'s plans to buy Wyeth but said that warrants no change in its corporate disclosure statement filed in the Wyeth v. Diana Levine drug preemption case pending before the court (Wyeth v. Diana Levine, No. 06-1249, U.S. Sup.; See November 2008, Page 8). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Stay In Paxil Preemption Appeal Extended Until May</title>
<description>
<![CDATA[SAN FRANCISCO - The stay of proceedings in a couple's appeal of a federal judge's finding that their failure-to-warn claims against the maker of Paxil are preempted by U.S. Food and Drug Administration regulations was extended until May 11, according to an order docketed Feb. 19 in the Ninth Circuit U.S. Court of Appeals (Terri S. O'Neal v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. No. 08-16182, 9th Cir.; See January 2009, Page 9). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Magistrate Judge Compels GSK To Produce Paxil Revenue, Profit Data</title>
<description>
<![CDATA[HAMMOND, Ind. - A federal magistrate judge on Feb. 3 ordered SmithKline Beecham Corp., d/b/a GlaxoSmithKline (GSK), to produce information related to the profit and revenue it received from pediatric sales of Paxil in Indiana and the United States from 2000 to 2004 to a family who claims that the antidepressant caused a 14-year-old boy to commit suicide in 2001, after finding that the information is relevant to their claim for punitive damages (Cheryl Cunningham, et al. v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 07-CV-174, N.D. Ind.; 2009 U.S. Dist. LEXIS 7833; See August 2008, Page 16). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>MDL Plaintiffs Seek Access To Clinical Trial Documents</title>
<description>
<![CDATA[ST. LOUIS - Plaintiffs in the Celexa and Lexapro multidistrict litigation say in a Feb. 13 motion to compel that they should be given access to hard copy documents in the antidepressants' clinical trial files because the information is "the most pure and objective form" of knowledge available (In re: Celexa/Lexapro Products Liability Litigation, MDL No. 1736, Case No. 06-md-1736, E.D. Mo.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Wyeth Seeks To Supplement Plaintiff's Deposition Based On New Evidence</title>
<description>
<![CDATA[PITTSBURGH - A plaintiff's failure to respond to Wyeth's requests for additional information regarding his own attempted suicide considering he alleges in his lawsuit that his brother's use of Effexor caused his suicide warrants the entry of a court order compelling the plaintiff to appear for a supplemental deposition, the manufacturer argues in a Jan. 29 motion to compel (Dale Aaron v. Wyeth, No. 07-927, W.D. Pa.; See November 2007, Page 16). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Woman Says Good Faith, Facts Of Case Warrant Denial Of Costs</title>
<description>
<![CDATA[ROME, Ga. - A woman whose Paxil suicide lawsuit was found to be barred by the learned intermediary doctrine says in a Feb. 16 brief that a federal judge has discretion to relieve her from paying costs because she litigated her claims against the maker of the antidepressant in good faith and because the facts of the case militate against the imposition of costs (Donna L. Dietz v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 07-cv-77-RLV, N.D. Ga.; See January 2009, Page 10). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Parties Jointly Move To Dismiss Paxil Suicide Attempt Case</title>
<description>
<![CDATA[BRATTLEBORO, Vt. - The manufacturer of Paxil and a woman who claims that her use of the antidepressant caused her to attempt suicide when she was 16 years old jointly moved Feb. 20 to dismiss with prejudice her lawsuit (Jennifer Elwell v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 07-CV-191, D. Vt.; See April 2007, Page 17). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Researchers Say SSRIs Reduce Suicide Risk In Adults</title>
<description>
<![CDATA[OTTAWA, Ontario - The authors of a recently published study in the Canadian Medial Association Journal concluded that the use of a family of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) by adult patients may reduce the risk of suicide. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-7 Mealeys Antidepressant Drugs 11%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>FDA Approves Updated Warning For SSRI, SNRI Makers</title>
<description>
<![CDATA[SILVER SPRING, Md. - The U.S. Food and Drug Administration on Jan. 30 informed manufacturers of numerous selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) that it has approved updated warning language regarding the risk of neuroleptic malignant syndrome (NMS) that they companies need to add to their products' labels. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-7 Mealey's Antidepressant Drugs 11 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 1%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Judge Asks If Birth Defect Case Should Stay In MDL</title>
<description>
<![CDATA[ST. LOUIS - The federal judge presiding over the Celexa and Lexapro multidistrict litigation asked the parties on Jan. 22 to submit memoranda explaining why a birth defect case and a death case should remain in the proceedings (In re: Celexa &amp; Lexapro Products Liability Litigation, MDL No. 1736, E.D. Mo.; 2009 U.S. Dist. LEXIS 4204; See August 2008, Page 6). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 1 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 2%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Judge Refers Discovery Dispute To Magistrate Judge</title>
<description>
<![CDATA[TULSA, Okla. - SmithKline Beecham Corp. d/b/a GlaxoSmithKline's (GSK) request to modify a special judge's report and recommendation concerning its privilege assertions over documents requested in a Paxil birth defect case was referred to a magistrate judge by a federal judge on Jan. 12 (Jennifer Hayes and Justin Hayes v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 07-CV-0682, N.D. Okla.; See December 2008, Page 13). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 2 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 3%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Oral Arguments On Paxil Limitations Ruling Scheduled For March 10</title>
<description>
<![CDATA[DENVER - The 10th Circuit U.S. Court of Appeals will hear oral arguments on March 10 over whether a federal judge in Kansas properly found that a woman's claims that SmithKline Beecham Corp. d/b/a GlaxoSmithKline's (GSK) fraudulent concealment of its knowledge concerning the risk between Paxil and an increased risk of suicide in adolescent patients were insufficient to toll the statute of limitations, according to a scheduling order issued to counsel on Jan. 13 (Pamela Blain, et al. v. SmithKline Beecham Corp., Nos. 08-3131, 08-3140, 10th Cir.; See November 2008, Page 11). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 3 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 4%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Generic Paxil Case Remanded After Plaintiffs Amend Complaint</title>
<description>
<![CDATA[LAFAYETTE, La. - A federal magistrate judge on Dec. 16 remanded a family's wrongful death suit against a manufacturer of generic Paxil after they amended their complaint to name as a defendant the physician who prescribed and increased the dosage of the antidepressant to the decedent without first meeting him and monitoring his behavior when first using the drug (Mary Lee Delahoussaye, et al. v. Apotex Inc., et al., No. 07-1325, W.D. La.; See December 2008, Page 8). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 4 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 5%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>California Supreme Court Won't Review Ruling Holding Brand-Name Drug Maker Liable</title>
<description>
<![CDATA[SAN FRANCISCO - The California Supreme Court on Jan. 21 let stand an appeals court ruling that the brand-name manufacturer of a drug can be liable for a failure-to-warn claim involving the generic version of the drug (Elizabeth Ann Conte v. Wyeth, et al., No. S169116, Calif. Sup.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 5 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 6%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Paxil Preemption Appeal Stay Extended To March 10</title>
<description>
<![CDATA[SAN FRANCISCO - The stay of a couple's appeal of a federal judge's rulings finding their failure-to-warn claims against Paxil manufacturer SmithKline Beecham d/b/a GlaxoSmithKline (GSK) preempted by Food and Drug Administration regulations was extended to March 10, according to a Jan. 9 order filed in the Ninth Circuit U.S. Court of Appeals (Terri S. O'Neal, et al. v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 08-16182, 9th Cir.; See October 2008, Page 5). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 6 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 7%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Appellate Panel Finds Evidence Does Not Support Involuntary Intoxication Claim</title>
<description>
<![CDATA[SAN FRANCISCO - A California appeals panel on Jan. 2 affirmed the conviction of a man found guilty of murdering his wife, finding that there was insufficient evidence to warrant reversal of the trial court's decision not to instruct the jury on his argument that he was unconscious by involuntary intoxication brought about by his use of Paxil at the time of the crime (People v. Simon Faeed Ranteesi, No. A115311, Calif. App., 1st Dist., Div. 2; 2009 Cal. App. LEXIS 20). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 7 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 8%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Widow Asks Judge To Limit, Defer Costs From Paxil Suit</title>
<description>
<![CDATA[ROME, Ga. - A widow whose wrongful death suit against the maker of Paxil was recently dismissed asked a federal judge on Jan. 22 to limit the amount of costs the company is awarded and requested that any such payments be deferred until the completion of her appeal (Donna Dietz v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 07-CV-0077-RLV, N.D. Ga.; See December 2008, Page 10). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 8 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 9%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Canadian Drug Company Serves Notice Of Arbitration On United States Under NAFTA</title>
<description>
<![CDATA[WASHINGTON, D.C. - Apotex Inc., a Canadian pharmaceutical company, served a notice of arbitration on the United States on Dec. 10, alleging that the United States violated Chapter 11 of the North American Free Trade Agreement (NAFTA) through federal court rulings that prevented the company from obtaining a declaratory judgment of patent noninfringement or invalidity and, therefore, from promptly bringing its generic product to the market (Apotex Inc. v. The Government of the United States of America, UNCITRAL). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 9 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 10%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Study: Zoloft, Lexapro Best For Moderate To Severe Depression</title>
<description>
<![CDATA[LONDON - Pfizer Inc.'s Zoloft and Forest Laboratories Inc.'s Lexapro, also known as Cipralex, should be a psychiatrist's first choice when deciding what drug to prescribe to a patient suffering from moderate to severe depression, according to the authors of a new study published in a recent online issue of Lancet who found that the drugs performed marginally better than 10 other antidepressants reviewed. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 10 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-6 Mealeys Antidepressant Drugs 11%20(2009)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Pfizer Plans To Acquire Wyeth For $68 Billion</title>
<description>
<![CDATA[NEW YORK - Pharmaceutical giant Pfizer Inc. announced Jan. 26 that it plans to acquire rival drug company Wyeth for $68 billion, resulting in what the company calls a "combined company that will create one of the most diversified companies in the global health care industry." 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-6 Mealey's Antidepressant Drugs 11 (2009)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 1%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>GSK Claims Ruling Excluding Expert's Opinion Was Correct</title>
<description>
<![CDATA[DENVER - A district court's ruling that a plaintiff's expert's opinions as to whether Paxil can cause suicidal behavior and that a man's use of the antidepressant caused him to take his own life in 2003 was not erroneous, the drug maker says in a Dec. 1 appellate brief, because the expert believed that such an association existed before the drug was approved by the Food and Drug Administration. (Debra Vanderwerf v. SmithKline Beecham Corp., No. 08-3218, 10th Cir.; See November 2008, Page 5). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 1 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 2%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>State Justice Finds Plaintiffs' Experts Qualified; Only 1 Can Testify</title>
<description>
<![CDATA[WORCESTER, Mass. - Only one expert can provide testimony in support of a man's claims that a physician was medically negligent when prescribing Wellbutrin to his wife before her suicide, a Massachusetts Superior Court justice ruled after finding that though both experts were qualified to proffer general and specific causation opinions, only one employed a proper methodology to support his opinions. (Allan Routhier v. Timothy G. Keenan, M.D., No. 04-1359, Mass. Super., 2008 Mass. Super. LEXIS 372). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 2 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 3%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Companies Say Preemption Ruling Is Not Worthy Of Certification</title>
<description>
<![CDATA[WASHINGTON, D.C. - A Third Circuit U.S. Court of Appeals ruling that plaintiffs' claims against the makers of Paxil and its generic equivalent and Zoloft are preempted by Food and Drug Administration regulations should not be reviewed by the U.S. Supreme Court because the ruling is not erroneous, the makers of the antidepressants say in briefs filed Dec. 3 (Joseph Colacicco, et al. v. Apotex Inc, et al., No. 08-437, U.S. Sup.; See October 2008, Page 4.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 3 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 4%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Generic Paxil Maker Again Raises Preemption Defense</title>
<description>
<![CDATA[LAFAYETTE, La. - A generic Paxil maker is seeking summary judgment based on the preemption defense in a wrongful death case, slightly more than a year after a federal judge denied its motion to dismiss the case on the ground that the manufacturer had both "the power and the duty" to add a stronger suicide warning to the antidepressant's label (Mary Lee Delahoussaye, et al. v. Apotex Inc., et al., No. 07-1325, W.D. La.; See November 2007, Page 4). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 4 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 5%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Plaintiffs Fail To Plead Exception To Michigan Law, Appeals Court Rules</title>
<description>
<![CDATA[NEW YORK - A New York appeals court on Nov. 20 affirmed that Michigan state law applies to the Lipitor injury claims of three plaintiffs and that they had not provided a foundation for their argument that their claims fell under the fraud exception to Michigan's drug shield law (Michael Devore, et al. v. Pfizer Inc., Nos. 109838/06, 109845/06, 109847/06, N.Y. Sup., App. Div., 1st Dept.; 2008 N.Y. App. Div. 8707). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 5 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 6%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>GSK Awarded Summary Judgment In Paxil Suicide Case</title>
<description>
<![CDATA[ROME, Ga. - The manufacturer of Paxil's assertion that the learned intermediary doctrine bars a widow's claims that it is liable for her husband's April 2002 suicide was upheld by a federal judge on Dec. 9, after finding that the 11th Circuit U.S. Court of Appeals recently held that a plaintiff cannot prove proximate causation if the prescribing physician testifies that his or her decision to prescribe a drug would not have been altered by a stronger warning. (Donna Dietz v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 07-CV-0077-RLV, N.D. Ga.; See April 2007, Page 22). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 6 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 7%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Man Says Lilly's Summary Judgment Motion Is A Waste Of Time</title>
<description>
<![CDATA[ATLANTA - A motion for summary judgment filed by the maker of Prozac in a case involving claims that the antidepressant caused a man to experience a manic episode resulting in his incarceration is a waste of time, the plaintiff says in a Nov. 26 brief, explaining that the two arguments raised in the motion have already been rejected by a Georgia state court judge (Tom Watkins v. Eli Lilly &amp; Company, No. 08-CV-1665 JEC, N.D. Ga.; See November 2008, Page 6). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 7 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 8%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Plaintiffs: Lilly Has 'Unbelievable Chutzpah' To Seek Review</title>
<description>
<![CDATA[ALBUQUERQUE, N.M. - The maker of Prozac should be estopped from seeking review of a judge's rulings denying its motions for summary judgment based on the learned intermediary doctrine and federal preemption and of his decision finding plaintiffs' expert's testimony admissible because it waited until after the judge issued the orders to ask him to disqualify himself, plaintiffs say in a Nov. 20 opposition brief (Mark Gilbert Rimbert v. Eli Lilly &amp; Co., No. 06-cv-874, D. N.M.; See October 2008, Page 10). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 8 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 9%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Couple's Request To Name Parent Company In Lawsuit Denied</title>
<description>
<![CDATA[TULSA, Okla. - A couple's attempt to add GlaxoSmithKline plc (GSK plc) and GlaxoSmithKline Research and Development (GSK R&amp;D) as defendants in their Paxil birth defect lawsuit was rejected by a federal judge, who concluded that they could not pursue claims against the companies because they were not involved in the marketing and manufacture of the antidepressant (Jennifer Hayes and Justin Hayes v. SmithKline Beecham Corp., d/b/a GlaxoSmithKline, No. 07-CV-0682, N.D. Okla.; 2008 U.S. Dist. LEXIS 94697). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 9 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-5 Mealeys Antidepressant Drugs 10%20(2008)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Lilly Employee Should Be Ordered To Appear Live At Trial, Couple Says</title>
<description>
<![CDATA[SIOUX FALLS, S.D. - An Eli Lilly &amp; Co. employee who studied and wrote articles about the association between Prozac and suicidal behavior should be ordered to appear live at a trial involving claims brought by a couple who claim that their son's use of Cymbalta caused him to commit suicide, the parents say, because his knowledge is germane to their underlying allegations and because the court has the power to compel his presence (Paul and Cynthia Schilf v. Eli Lilly &amp; Co., et al., No. 07CV04015-LLP, D. S.D.; See October 2008, Page 8). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=5-5 Mealey's Antidepressant Drugs 10 (2008)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
  
</channel>

</rss> 